Feeling left out, Prime Therapeutics sent me its heretofore unpublished 2013-2015 forecasts. So, today’s article is a Drug Channels exclusive. Highlights:
- Prime expects traditional trend to be much higher than either Express Scripts or CVS Caremark. See below for their explanation.
- Prime’s specialty forecast is comparable to the outlook from the big two PBMs.
- In 2017, Prime expects specialty drugs to be 50% of combined pharmacy and medical benefit drug spending.
Check back in three years and we’ll see which PBM turned out to be right. In the meantime, Prime has started a Drug Trend blog.